Aethlon Medical, Inc. (AEMD)
USD 0.35
(-4.54%)
USD 0.35
(-4.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -12.63 Million USD | -6.2% |
| 2023 | -11.89 Million USD | -14.18% |
| 2022 | -10.42 Million USD | -32.05% |
| 2021 | -7.89 Million USD | -33.08% |
| 2020 | -5.92 Million USD | 1.15% |
| 2019 | -5.99 Million USD | -24.17% |
| 2018 | -4.83 Million USD | 20.78% |
| 2017 | -6.09 Million USD | -39.08% |
| 2016 | -4.38 Million USD | -9.82% |
| 2015 | -3.99 Million USD | -30.66% |
| 2014 | -3.05 Million USD | 14.53% |
| 2013 | -3.57 Million USD | -14.8% |
| 2012 | -3.11 Million USD | 31.66% |
| 2011 | -4.55 Million USD | -59.96% |
| 2010 | -2.84 Million USD | 2.54% |
| 2009 | -2.92 Million USD | -1.06% |
| 2008 | -2.89 Million USD | -38.78% |
| 2007 | -2.08 Million USD | 0.51% |
| 2006 | -2.09 Million USD | 4.05% |
| 2005 | -2.18 Million USD | -119.31% |
| 2004 | -995.54 Thousand USD | 39.19% |
| 2003 | -1.63 Million USD | 27.97% |
| 2002 | -2.27 Million USD | -8.51% |
| 2001 | -2.09 Million USD | -135.44% |
| 2000 | -889.69 Thousand USD | -161.23% |
| 1999 | -340.57 Thousand USD | -9363.13% |
| 1998 | -3599.00 USD | -134.62% |
| 1997 | -1534.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.17 Million USD | 6.83% |
| 2024 Q1 | -3.4 Million USD | -37.54% |
| 2024 Q4 | -2.48 Million USD | 7.73% |
| 2024 FY | -12.63 Million USD | -6.2% |
| 2024 Q3 | -2.69 Million USD | 15.15% |
| 2023 Q3 | -2.84 Million USD | 22.25% |
| 2023 Q1 | -2.9 Million USD | 23.24% |
| 2023 Q2 | -3.66 Million USD | -26.13% |
| 2023 FY | -11.89 Million USD | -14.18% |
| 2023 Q4 | -2.47 Million USD | 13.05% |
| 2022 FY | -10.42 Million USD | -32.05% |
| 2022 Q1 | -2.09 Million USD | 7.34% |
| 2022 Q2 | -2 Million USD | 4.27% |
| 2022 Q4 | -3.78 Million USD | -49.75% |
| 2022 Q3 | -2.52 Million USD | -25.84% |
| 2021 FY | -7.89 Million USD | -33.08% |
| 2021 Q2 | -1.77 Million USD | -25.59% |
| 2021 Q4 | -2.26 Million USD | 7.36% |
| 2021 Q3 | -2.44 Million USD | -37.99% |
| 2021 Q1 | -1.41 Million USD | 20.99% |
| 2020 Q4 | -1.78 Million USD | -103.69% |
| 2020 Q1 | -1.56 Million USD | 1.55% |
| 2020 FY | -5.92 Million USD | 1.15% |
| 2020 Q2 | -1.7 Million USD | -8.68% |
| 2020 Q3 | -876.4 Thousand USD | 48.51% |
| 2019 Q1 | -1.09 Million USD | 13.67% |
| 2019 Q2 | -1.34 Million USD | -22.75% |
| 2019 Q3 | -1.96 Million USD | -45.8% |
| 2019 Q4 | -1.59 Million USD | 18.99% |
| 2019 FY | -5.99 Million USD | -24.17% |
| 2018 FY | -4.83 Million USD | 20.78% |
| 2018 Q3 | -1.16 Million USD | 5.87% |
| 2018 Q2 | -1.23 Million USD | -6.54% |
| 2018 Q1 | -1.16 Million USD | 22.87% |
| 2018 Q4 | -1.27 Million USD | -9.23% |
| 2017 Q4 | -1.5 Million USD | -21.75% |
| 2017 FY | -6.09 Million USD | -39.08% |
| 2017 Q3 | -1.23 Million USD | 44.51% |
| 2017 Q2 | -2.22 Million USD | -96.76% |
| 2017 Q1 | -1.13 Million USD | -4.17% |
| 2016 FY | -4.38 Million USD | -9.82% |
| 2016 Q3 | -1.08 Million USD | 3.58% |
| 2016 Q2 | -1.12 Million USD | -3.16% |
| 2016 Q4 | -1.08 Million USD | -0.21% |
| 2016 Q1 | -1.08 Million USD | 3.77% |
| 2015 Q4 | -1.13 Million USD | -4.2% |
| 2015 FY | -3.99 Million USD | -30.66% |
| 2015 Q1 | -1.17 Million USD | -44.69% |
| 2015 Q2 | -601.19 Thousand USD | 48.7% |
| 2015 Q3 | -1.08 Million USD | -80.8% |
| 2014 Q1 | -783.79 Thousand USD | 7.45% |
| 2014 Q2 | -229.79 Thousand USD | 70.68% |
| 2014 Q3 | -1.23 Million USD | -436.28% |
| 2014 Q4 | -809.99 Thousand USD | 34.27% |
| 2014 FY | -3.05 Million USD | 14.53% |
| 2013 Q4 | -846.93 Thousand USD | 9.6% |
| 2013 FY | -3.57 Million USD | -14.8% |
| 2013 Q1 | -990.8 Thousand USD | -15.54% |
| 2013 Q2 | -799.79 Thousand USD | 19.28% |
| 2013 Q3 | -936.83 Thousand USD | -17.14% |
| 2012 FY | -3.11 Million USD | 31.66% |
| 2012 Q2 | -882.95 Thousand USD | 14.48% |
| 2012 Q1 | -1.03 Million USD | -10.02% |
| 2012 Q3 | -341.32 Thousand USD | 61.34% |
| 2012 Q4 | -857.57 Thousand USD | -151.25% |
| 2011 Q4 | -938.42 Thousand USD | 10.34% |
| 2011 Q1 | -1.16 Million USD | -76.45% |
| 2011 FY | -4.55 Million USD | -59.96% |
| 2011 Q2 | -1.4 Million USD | -21.28% |
| 2011 Q3 | -1.04 Million USD | 25.75% |
| 2010 Q3 | -715.97 Thousand USD | 10.26% |
| 2010 Q4 | -658.71 Thousand USD | 8.0% |
| 2010 Q1 | -641.95 Thousand USD | 8.24% |
| 2010 Q2 | -797.87 Thousand USD | -24.29% |
| 2010 FY | -2.84 Million USD | 2.54% |
| 2009 Q2 | -732.65 Thousand USD | -17.48% |
| 2009 Q1 | -623.65 Thousand USD | 22.46% |
| 2009 Q3 | -867.36 Thousand USD | -18.39% |
| 2009 Q4 | -699.56 Thousand USD | 19.35% |
| 2009 FY | -2.92 Million USD | -1.06% |
| 2008 Q1 | -871.27 Thousand USD | -50.26% |
| 2008 Q2 | -690.02 Thousand USD | 20.8% |
| 2008 Q3 | -526.97 Thousand USD | 23.63% |
| 2008 FY | -2.89 Million USD | -38.78% |
| 2008 Q4 | -804.31 Thousand USD | -52.63% |
| 2007 Q4 | -579.82 Thousand USD | -24.7% |
| 2007 FY | -2.08 Million USD | 0.51% |
| 2007 Q3 | -464.99 Thousand USD | 13.08% |
| 2007 Q2 | -534.94 Thousand USD | -6.6% |
| 2007 Q1 | -501.83 Thousand USD | -61.12% |
| 2006 Q1 | -735.06 Thousand USD | -19.88% |
| 2006 FY | -2.09 Million USD | 4.05% |
| 2006 Q4 | -311.47 Thousand USD | 36.95% |
| 2006 Q3 | -494.01 Thousand USD | 10.89% |
| 2006 Q2 | -554.38 Thousand USD | 24.58% |
| 2005 Q1 | -458.37 Thousand USD | -50.26% |
| 2005 FY | -2.18 Million USD | -119.31% |
| 2005 Q2 | -561.94 Thousand USD | -22.6% |
| 2005 Q3 | -549.9 Thousand USD | 2.14% |
| 2005 Q4 | -613.15 Thousand USD | -11.5% |
| 2004 FY | -995.54 Thousand USD | 39.19% |
| 2004 Q3 | -188.68 Thousand USD | 28.84% |
| 2004 Q1 | -188.41 Thousand USD | 67.04% |
| 2004 Q2 | -265.13 Thousand USD | -40.72% |
| 2004 Q4 | -305.04 Thousand USD | -61.67% |
| 2003 FY | -1.63 Million USD | 27.97% |
| 2003 Q4 | -571.61 Thousand USD | -77.36% |
| 2003 Q2 | -476.29 Thousand USD | -50.0% |
| 2003 Q3 | -322.29 Thousand USD | 32.33% |
| 2003 Q1 | -317.52 Thousand USD | 66.04% |
| 2002 Q4 | -934.94 Thousand USD | -131.16% |
| 2002 Q3 | -404.45 Thousand USD | 6.39% |
| 2002 Q2 | -432.05 Thousand USD | 14.65% |
| 2002 Q1 | -506.19 Thousand USD | 47.77% |
| 2002 FY | -2.27 Million USD | -8.51% |
| 2001 Q1 | -332.9 Thousand USD | -129.55% |
| 2001 Q4 | -969.24 Thousand USD | -124.68% |
| 2001 FY | -2.09 Million USD | -135.44% |
| 2001 Q3 | -431.38 Thousand USD | -19.45% |
| 2001 Q2 | -361.14 Thousand USD | -8.48% |
| 2000 Q2 | -252.76 Thousand USD | -42.45% |
| 2000 Q4 | -145.02 Thousand USD | 53.88% |
| 2000 Q3 | -314.45 Thousand USD | -24.4% |
| 2000 Q1 | -177.44 Thousand USD | 0.0% |
| 2000 FY | -889.69 Thousand USD | -161.23% |
| 1999 FY | -340.57 Thousand USD | -9363.13% |
| 1998 FY | -3599.00 USD | -134.62% |
| 1997 FY | -1534.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 12.008% |
| Cerus Corporation | -30.05 Million USD | 57.952% |
| OrthoPediatrics Corp. | -25.76 Million USD | 50.956% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -18.973% |
| Talis Biomedical Corporation | -66.81 Million USD | 81.087% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 26.939% |
| Inogen, Inc. | -109.38 Million USD | 88.448% |
| Spectral AI, Inc. | -12.98 Million USD | 2.676% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 79.81% |
| CVRx, Inc. | -43.1 Million USD | 70.683% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -258.179% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -1.678% |
| Orthofix Medical Inc. | -139.11 Million USD | 90.916% |
| Venus Concept Inc. | -28.3 Million USD | 55.362% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 76.611% |
| Bioventus Inc. | -81.72 Million USD | 84.538% |
| BrainsWay Ltd. | -4.92 Million USD | -156.476% |
| Envoy Medical, Inc. | -18.37 Million USD | 31.215% |
| electroCore, Inc. | -18.8 Million USD | 32.802% |
| IceCure Medical Ltd | -15.57 Million USD | 18.872% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 73.936% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 26.821% |
| MaxCyte, Inc. | -48.29 Million USD | 73.837% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -5.699% |
| Nexalin Technology, Inc. | -5.69 Million USD | -121.838% |
| PAVmed Inc | -68.79 Million USD | 81.632% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 77.659% |
| RxSight, Inc. | -50.08 Million USD | 74.77% |
| Sight Sciences, Inc. | -57.27 Million USD | 77.937% |
| SI-BONE, Inc. | -46.93 Million USD | 73.074% |
| TELA Bio, Inc. | -44.07 Million USD | 71.329% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 76.664% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 75.429% |
| LivaNova PLC | -68.49 Million USD | 81.552% |
| 908 Devices Inc. | -42.75 Million USD | 70.446% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 92.712% |
| Nemaura Medical Inc. | -9.59 Million USD | -31.696% |
| NeuroPace, Inc. | -27.17 Million USD | 53.498% |
| LENSAR, Inc. | -12.22 Million USD | -3.333% |
| Apyx Medical Corporation | -17.25 Million USD | 26.783% |
| Cutera, Inc. | -156.23 Million USD | 91.912% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -46.869% |
| BioSig Technologies, Inc. | -28.51 Million USD | 55.68% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 85.581% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 43.702% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 111.331% |
| Axonics, Inc. | -26.05 Million USD | 51.504% |
| Outset Medical, Inc. | -169.77 Million USD | 92.557% |
| IRIDEX Corporation | -10 Million USD | -26.277% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 88.425% |
| IRadimed Corporation | 20.03 Million USD | 163.071% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -53.263% |
| INVO Bioscience, Inc. | -6.76 Million USD | -86.734% |
| Telesis Bio, Inc. | -35.15 Million USD | 64.05% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 188.183% |
| Varex Imaging Corporation | 32.1 Million USD | 139.366% |
| Quipt Home Medical Corp. | 3.91 Million USD | 422.444% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -4.15% |
| Pulmonx Corporation | -61.93 Million USD | 79.597% |
| Dynatronics Corporation | -2.27 Million USD | -455.931% |
| Modular Medical, Inc. | -17.52 Million USD | 27.911% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 13.679% |
| Semler Scientific, Inc. | 22.25 Million USD | 156.778% |
| InMode Ltd. | 195.66 Million USD | 106.458% |
| Bruker Corporation | 436.9 Million USD | 102.892% |
| Cytosorbents Corporation | -31.2 Million USD | 59.51% |
| DexCom, Inc. | 597.7 Million USD | 102.114% |
| Align Technology, Inc. | 643.33 Million USD | 101.964% |
| Viveve Medical, Inc. | -21.55 Million USD | 41.37% |
| ZimVie Inc. | -30.93 Million USD | 59.157% |
| Movano Inc. | -29.69 Million USD | 57.438% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 54.618% |
| Nexalin Technology, Inc. | -5.69 Million USD | -121.838% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -258.179% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 94.582% |
| Profound Medical Corp. | -28.61 Million USD | 55.841% |
| Insulet Corporation | 220 Million USD | 105.744% |
| enVVeno Medical Corporation | -25.23 Million USD | 49.93% |
| Surmodics, Inc. | -5.64 Million USD | -123.854% |
| iCAD, Inc. | -7.68 Million USD | -64.346% |
| Nuwellis, Inc. | -17.63 Million USD | 28.323% |
| Biotricity, Inc. | -8.82 Million USD | -43.138% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 89.904% |
| InspireMD, Inc. | -21.14 Million USD | 40.233% |
| PAVmed Inc. | -68.79 Million USD | 81.632% |
| BIOLASE, Inc. | -17.93 Million USD | 29.55% |
| Beyond Air, Inc. | -63 Million USD | 79.944% |
| FONAR Corporation | 16.53 Million USD | 176.421% |
| AxoGen, Inc. | -21.46 Million USD | 41.121% |
| Vivani Medical, Inc. | -26.96 Million USD | 53.137% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 170.044% |
| Inari Medical, Inc. | -14.03 Million USD | 9.945% |
| UFP Technologies, Inc. | 57.66 Million USD | 121.914% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -156.445% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -100.397% |
| Tenon Medical, Inc. | -15.72 Million USD | 19.65% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -69.074% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 70.41% |
| AdaptHealth Corp. | -598.4 Million USD | 97.888% |
| Sintx Technologies, Inc. | -13.35 Million USD | 5.401% |
| NanoVibronix, Inc. | -3.43 Million USD | -267.77% |
| Quanterix Corporation | -49.7 Million USD | 74.575% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -4.15% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -3208.002% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 96.222% |
| TransMedics Group, Inc. | -28.72 Million USD | 56.012% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 46.482% |
| NeuroMetrix, Inc. | -7.15 Million USD | -76.698% |
| Hyperfine, Inc. | -48.11 Million USD | 73.737% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 80.567% |
| Biomerica, Inc. | -6.36 Million USD | -98.47% |
| Bone Biologics Corporation | -9.42 Million USD | -34.028% |
| AVITA Medical, Inc. | -40.4 Million USD | 68.723% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -22.552% |
| Silk Road Medical, Inc | -59.27 Million USD | 78.68% |